Matinas BioPharma Hldgs: Q1 Earnings Insights

Matinas BioPharma Hldgs MTNB reported its Q1 earnings results on Thursday, May 12, 2022 at 06:15 AM.

Here's what investors need to know about the announcement.

Earnings

Matinas BioPharma Hldgs missed estimated earnings by 50.0%, reporting an EPS of $-0.03 versus an estimate of $-0.02.

Revenue was down $33.33 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 7.04% increase in the share price the next day.

Here's a look at Matinas BioPharma Hldgs's past performance:

To track all earnings releases for Matinas BioPharma Hldgs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.